Moneycontrol PRO

business

A Democrat victory could hurt pharma sector: Ampersand Cap

Speaking to CNBC-TV18 Rahul Singh, Managing Partner at Ampersand Capital Investment Advisors said that from an earnings and a recovery perspective, they are turning more selective even in sectors that they like.

first published: Nov 8, 2016 11:53 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347